Global Portable Patient Isolation Markets, 2020-2021 & 2026: Major Innovations in HEPA Filters and Air Pressure Units for Containing Pathogens, Contact, and Droplet Nuclei

News provided by

Dec 30, 2020, 09:15 ET

DUBLIN, Dec. 30, 2020 /PRNewswire/ -- The "Portable Patient Isolation Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global portable patient isolation market by revenue is expected to grow at a CAGR of 13% during the period 2021-2026.

The demand for transport rooms and pods is likely to observe an impetus due to increased efforts to effectively isolate symptomatic or suspected patients suffering from COVID-19.

As the world is struggling to control and prevent the spread of coronavirus, vendors engaged in manufacturing and sales of patient isolation products are witnessing a surge for these products from medical and health facilities as well as military, defense, and government bodies. Improvements in global healthcare infrastructure and the adoption of cost-effective, energy-efficient, and sustainable resource dependence are the other main factors that are driving the market.

Global Portable Patient Isolation Market Segmentation

The global portable patient isolation market research report includes a detailed segmentation by product, end-user, readiness, geography. Increased innovations in transport pods and the outbreak of infected/contagious diseases are factors responsible for the adoption of pods in healthcare settings. APAC is expected to grow at the fastest CAGR during the forecast period on account of increased healthcare construction activities and a rise in private and public investments in the healthcare sector.

However, the important factor that is likely to influence the market is the introduction of innovative transportation pods. Vendors are offering pods with HEPA filters, while others are deploying proper ventilator hoses and well equipped with medical ports, sluice bags, gloves, and operator ports. The demand for transport pods has increased drastically with the breakout of the COVID-19 pandemic.

The demand for identification, containment, and treatment of infectious patients and the growth potential of portable patient isolation systems are likely to increase the adoption of treatment rooms and pods in the healthcare segment. The high prevalence of viral, bacterial, and antibiotic-resistance microbial infections has encouraged end-users to invest in portable pods to prevent infections acquired in hospitals.

Epidemics have highlighted the importance of large-scale, portable infrastructure POC/rapid tests for public health needs and patient outcomes as well as to fill gaps in current diagnostic testing methodologies. Therefore, the increase in the number of people suffering from infections is encouraging physicians in hospitals to portable pods, thereby contributing to the growth of the segment.

Instant portable patient isolation pods and rooms can be operational in less than 15 minutes. These pods are used to shift infectious patients to medical facilities along with that person with chemical, biological, pathogenic, radioactive, and nuclear contamination. These products are finding applications among end-users as they are more cost and space-effective solutions than conventional and fixed isolation rooms.

Non-instant isolation products have a high adoption in government and public sectors as they generally consist of multi-patient isolation products, including negative pressure and anterooms fixtures. Such products can provide effective isolation for multiple patients and can be easily dismantled and moved to another location with the spread of infections.

INSIGHTS BY GEOGRAPHY

In light of the outbreak of the corona pandemic, the healthcare sector is expected to emerge immune from political uncertainties prevailing over Europe post the Brexit negotiations, which are expected to affect the economic growth adversely. Vendors of portable patient isolation products have been able to meet new orders in H1 2020, despite lockdown in several countries.

The increased pressure to enhance infection capabilities and control the spread of the coronavirus virus across Europe is expected to augur well for the market. Moreover, the growth of portable patient isolation products in Europe is mainly supported by growing investments and government spending on the healthcare infrastructure and preparedness to manage the second wave of the coronavirus.

INSIGHTS BY VENDORS

One of the major innovations in the market is the introduction of HEPA filters and air pressure units, which are capable of containing pathogens, contact, and droplet nuclei, and are capable of generating negative and positive pressures.

Vendors with better technical and financial resources can develop innovative products that could pose a threat to competitor products, making them non-competitive and even obsolete before they can recover R&D and commercialization costs. Therefore, vendors must develop new technologies and remain abreast of upcoming innovations to have a competitive advantage over other vendors.

Prominent Vendors

Gama Healthcare
ATA
Alaska Structures
RGF Environmental Group
Beth-El Industries
Isoport Chamber
American Biomedical Group
Abatement Technologies
Alliance Environmental Group
Safespear
Siliconecube
Isovac Products
Airboss Of America
Epiguard
Ecolab
Odulair
PPS
Bubble Bunker
LIRI Tent
HDT Global
Biobase
Ego Zlin

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.2 Base Year
4.3 Scope Of The Study
4.4 Market Segments

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Overview
7.2 Impact Of COVID-19

8 Market Opportunities & Trends
8.1 Demand For Hospital Beds Present Growth Avenues
8.2 Potential In New Hospital Constructions

9 Market Growth Enablers
9.1 Onset Of Pandemic And Infection Outbreaks
9.2 Increase In Target Population With Infectious Diseases
9.3 Advances In Diagnostic Tools And Assay

10 Market Restraints
10.1 Advanced Mechanisms To Control Infection Spread In Healthcare Settings
10.2 Declining Prevalence Of Infections In Developed Markets

11 Market Landscape
11.1 Market Overview
11.2 Five Forces Analysis

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 PODS
12.4 Rooms

13 End-Users
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Healthcare
13.4 Defense & Others

14 Readiness
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Instant
14.4 Non-Instant

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview

For more information about this report visit https://www.researchandmarkets.com/r/uppasa

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets